Novelrad
Minimally-invasive Suturing for Vascular and Heart Defect Closure
Company Overview
Snapshot
Founded in January 2019 by Netanel Sharabani and Ori Goldor, Novelrad operates with 1–10 employees. The company secured a grant from EIC Accelerator in February 2024, marking a significant milestone in its development.
Business overview
Novelrad develops a micro sewing machine designed for minimally-invasive suturing, specifically targeting vascular and heart defect closure. This versatile suturing platform mimics surgical gold standards, enabling the deployment of continuous suture patterns percutaneously. The device facilitates safe dilation and reliable closure by deploying a multipoint purse string suture at the beginning of procedures, addressing multiple indications within the cardiovascular system and beyond. Novelrad operates within the Health Tech & Life Sciences sector, focusing on medical devices and medical treatment & therapeutics for healthcare providers.
Strategic signal
In February 2024, Novelrad received a grant from the EIC Accelerator. This recognition from a prominent European innovation program validates the potential of Novelrad's micro sewing machine technology for minimally-invasive vascular and heart defect closure, signaling strong institutional confidence in its innovative approach and market relevance.
Log in to access full profile ›Company Intelligence Q&A
- When was Novelrad founded and by whom?
- Novelrad was founded in January 2019 by co-founders Netanel Sharabani and Ori Goldor.
- What was a significant development for Novelrad in early 2024?
- In February 2024, Novelrad received a grant from the EIC Accelerator, as part of the November 2023 cut-off results.
- What is the primary application of Novelrad's device?
- The device is designed for minimally-invasive suturing for vascular and heart defect closure, mimicking surgical 'gold standard' techniques.
- How does Novelrad's device facilitate surgical procedures?
- The Novelrad VCD deploys a multipoint purse string suture at the beginning of a procedure, enabling safe dilation and reliable closure, and offers an unprecedented range of bore sizes using a single device.